Shares of AngioDynamics, Inc. (ANGO) have traded between $13.73 – 25.48. The next earnings date is set for Apr 07, 2020. Let’s see how its prospects are shaping up.

What does AngioDynamics, Inc.(ANGO) do?

AngioDynamics, Inc. engages in the development, manufacture, and sale of medical devices for vascular access, surgery, peripheral vascular disease, and oncology. It offers ablation systems, fluid management systems, vascular access, angiographic, drainage. thrombolytic, and venous products. The company was founded by Eamonn P. Hobbs in 1988 and is headquartered in Latham, NY.

ANGO Insider Trading Insight

On 2019-10-25, Clemmer James C Pres, CEO purchased 15,000 shares of ANGO. That represents a value of $260,418. Not to be outdone, on 2019-07-16, Gould Kevin J S – Sale+OE sold13,650 shares of ANGO. These insiders are clearly in the know because they work closely with the company.

The GWB Consensus Price Target

The mean recommendation of Great Western Bancorp, Inc. from top Wall Street analysts is a Hold. That is based on 2 analysts who work on the Street. Based on 2 analysts offering 12 month price targets for Great Western Bancorp in the last 3 months. The average price target is $37.00 with a high forecast of $37.00 and a low forecast of $37.00. The average price target represents a 11.14% increase from the last price of $33.29. Last week, several articles were published in financial papers about GWB and 38% Bearish while 62% Bullish.

GWB Intraday Trading

GWB is due to report earnings on Jan 28, 2020. In the last year the price has ranged from 28.06 – 38.78. Recently, Karels Kenneth James sold 35,000 shares of GWB. He is a $138,414 shareholder in GWB.

Looking for stocks similar to ANGO and GWB?

Here are some stocks to consider: